Overview
🌐 Website:
💲 Revenue:
📍 Address:
👥 Employees:
🗓️ Established: 2006
📅 Published: February 1, 2021
✏️ Last updated: March 30, 2026
🌐 Website:
💲 Revenue:
📍 Address:
👥 Employees:
🗓️ Established: 2006
📅 Published: February 1, 2021
✏️ Last updated: March 30, 2026
AskAI Summary of Clinical ink
Generated using ISVWorld's AskAI proprietary software industry model.
📝 AskAI Recap: Clinical ink develops and sells a suite of clinical trial software products including eSource data capture, electronic Clinical Outcome Assessments (eCOA), eConsent, telehealth solutions, and digital biomarkers to support decentralized clinical trials and patient-centric research.
💬 Inclusion Rationale: Clinical ink offers product software platforms such as eSource, eCOA, and digital biomarker solutions that are developed and sold to clinical trial sponsors and CROs, indicating they are an ISV providing software products rather than only custom software services or hardware.
Based on AskAI classifications for Clinical ink, ISVWorld identifies comparable software companies in the same revenue range, related software categories, and major geographic regions. This view helps compare Clinical ink with active ISVs and software vendors across Clinical Trial Software, eCOA, Decentralized Clinical Trials markets.
75
Active software companies in the $10M to $25M revenue range classified under Clinical Trial Software.
4
Active software companies in the $10M to $25M revenue range classified under eCOA.
2
Active software companies in the $10M to $25M revenue range classified under Decentralized Clinical Trials.
366
Active software companies in North America matching any of Clinical ink's AskAI classifications.
192
Active software companies in Europe matching any of Clinical ink's AskAI classifications.
61
Active software companies in Asia matching any of Clinical ink's AskAI classifications.